• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低MELD评分患者腹水和血清钠的预后意义

Prognostic Significance of Ascites and Serum Sodium in Patients with Low Meld Scores.

作者信息

Prohic Dzanela, Mesihovic Rusmir, Vanis Nenad, Puhalovic Amra

机构信息

Department of Gastroenterohepatology, University Clinical Center Sarajevo, Bosnia and Herzegovina.

出版信息

Med Arch. 2016 Feb;70(1):48-52. doi: 10.5455/medarh.2016.70.48-52. Epub 2016 Jan 31.

DOI:10.5455/medarh.2016.70.48-52
PMID:26980932
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4779358/
Abstract

OBJECTIVE

to determine ascites and serum sodium significance in short term mortality prediction in patients with advanced liver cirrhosis.

METHODS

a cohort of 115 cirrhotic patients referred to our Department were followed up for 6 months in non-transplant settings. The c index equivalent to the area under the receiver operating curve (ROC) was calculated and compared to estimate the short-term prognostic accuracy of the following parameters: ascites, serum sodium and MELD score.

RESULTS

in patients with a MELD score less than 21, ascites and low serum sodium (c index 0,687, p<0 0,001 and 0,748, p<0,001 respectively) showed better prognostic accuracy and were independent predictors of mortality. For MELD scores above 21, only MELD was an independent mortality prognostic factor (c index 0,710, p<0,001).

CONCLUSION

in our study, sample ascites and low serum sodium help identify patients with advanced liver disease who are at high risk of mortality despite low MELD scores. These parameters should be considered as additional prognostic parameters that could improve available treatment options and outcomes in this group of patients.

摘要

目的

确定腹水和血清钠在晚期肝硬化患者短期死亡率预测中的意义。

方法

对转诊至我科的115例肝硬化患者在非移植情况下进行了6个月的随访。计算并比较了与受试者工作特征曲线(ROC)下面积等效的c指数,以评估以下参数的短期预后准确性:腹水、血清钠和终末期肝病模型(MELD)评分。

结果

在MELD评分低于21的患者中,腹水和低血清钠(c指数分别为0.687,p<0.001和0.748,p<0.001)显示出更好的预后准确性,并且是死亡率的独立预测因素。对于MELD评分高于21的患者,只有MELD是独立的死亡率预后因素(c指数0.710,p<0.001)。

结论

在我们的研究中,样本腹水和低血清钠有助于识别晚期肝病患者,这些患者尽管MELD评分较低,但仍有高死亡风险。这些参数应被视为额外的预后参数,可改善该组患者的现有治疗选择和结局。

相似文献

1
Prognostic Significance of Ascites and Serum Sodium in Patients with Low Meld Scores.低MELD评分患者腹水和血清钠的预后意义
Med Arch. 2016 Feb;70(1):48-52. doi: 10.5455/medarh.2016.70.48-52. Epub 2016 Jan 31.
2
Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.持续性腹水和低血钠可识别出肝硬化且终末期肝病模型(MELD)评分低但早期死亡风险高的患者。
Hepatology. 2004 Oct;40(4):802-10. doi: 10.1002/hep.20405.
3
Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.终末期肝病评分与血清钠比值指数模型作为肝硬化患者预后预测指标的验证
J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.
4
Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.比较PDD-吲哚菁绿清除试验、CTP、MELD和MELD-Na预测失代偿期乙型肝炎肝硬化患者短期和中期死亡率的能力。
Eur J Gastroenterol Hepatol. 2016 Apr;28(4):444-8. doi: 10.1097/MEG.0000000000000538.
5
A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.肝硬化患者不同预后模型的修订范围:当前与未来展望,埃及的经验
Arab J Gastroenterol. 2013 Dec;14(4):158-64. doi: 10.1016/j.ajg.2013.08.007. Epub 2013 Sep 29.
6
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation.终末期肝病模型(MELD)评分和血清钠水平对等待肝移植的肝硬化患者生存情况的预测作用
Gut. 2007 Sep;56(9):1283-90. doi: 10.1136/gut.2006.102764. Epub 2007 Apr 23.
7
[Serum sodium concentration profile for cirrhotic patients and its effect on the prognostic value of the MELD score].[肝硬化患者的血清钠浓度概况及其对终末期肝病模型(MELD)评分预后价值的影响]
Zhonghua Gan Zang Bing Za Zhi. 2012 Feb;20(2):108-11. doi: 10.3760/cma.j.issn.1007-3418.2012.02.008.
8
Serum sodium predicts mortality in patients listed for liver transplantation.血清钠可预测列入肝移植名单患者的死亡率。
Hepatology. 2005 Jan;41(1):32-9. doi: 10.1002/hep.20517.
9
Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.终末期肝病模型、门静脉压力和血清钠在肝硬化患者预后预测中的相关性及比较
J Clin Gastroenterol. 2007 Aug;41(7):706-12. doi: 10.1097/MCG.0b013e31802dabb3.
10
[Prognostic value of the model for end-stage liver disease combined with serum sodium levels in patients with decompensated cirrhosis].终末期肝病模型联合血清钠水平对失代偿期肝硬化患者的预后价值
Zhonghua Gan Zang Bing Za Zhi. 2012 Dec;20(12):896-901. doi: 10.3760/cma.j.issn.1007-3418.2012.12.005.

引用本文的文献

1
Management of refractory ascites.难治性腹水的处理。
Clin Mol Hepatol. 2023 Jan;29(1):16-32. doi: 10.3350/cmh.2022.0104. Epub 2022 Jun 9.
2
Development and Validation of a Prognostic Model for One-year Survival of Cirrhosis Patients with First-ever Spontaneous Bacterial Peritonitis.首次发生自发性细菌性腹膜炎的肝硬化患者一年生存率预后模型的开发与验证
J Clin Transl Hepatol. 2021 Oct 28;9(5):647-654. doi: 10.14218/JCTH.2021.00031. Epub 2021 May 24.
3
A Comprehensive Review of Outcome Predictors in Low MELD Patients.低 MELD 患者预后预测因素的全面综述。

本文引用的文献

1
The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites.终末期肝病钠模型(Refit model for end-stage liver disease-Na)并不优于终末期肝病模型(Refit model for end-stage liver disease)预测肝硬化伴腹水患者的死亡率。
Clin Mol Hepatol. 2014 Mar;20(1):47-55. doi: 10.3350/cmh.2014.20.1.47. Epub 2014 Mar 26.
2
The evolution in the prioritization for liver transplantation.肝移植优先级的演变。
Ann Gastroenterol. 2012;25(1):6-13.
3
Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature.
Transplantation. 2020 Feb;104(2):242-250. doi: 10.1097/TP.0000000000002956.
基于移植前 MELD 评分预测肝移植后的生存率:文献系统评价。
PLoS One. 2013 Dec 12;8(12):e80661. doi: 10.1371/journal.pone.0080661. eCollection 2013.
4
Ascites and serum sodium are markers of increased waiting list mortality in children with chronic liver failure.腹水和血清钠是慢性肝功能衰竭儿童等待名单死亡率增加的标志物。
Hepatology. 2014 May;59(5):1964-71. doi: 10.1002/hep.26776. Epub 2014 Apr 1.
5
Introduction to the revised American Association for the Study of Liver Diseases Practice Guideline management of adult patients with ascites due to cirrhosis 2012.2012年美国肝病研究协会肝硬化所致成人腹水患者管理实践指南修订版介绍。
Hepatology. 2013 Apr;57(4):1651-3. doi: 10.1002/hep.26359.
6
Hyponatremia: clinical associations, prognosis, and treatment in cirrhosis.低钠血症:肝硬化中的临床关联、预后及治疗
Exp Clin Transplant. 2013 Feb;11(1):3-11. doi: 10.6002/ect.2012.0147.
7
Natural history of cirrhosis.肝硬化的自然史。
Curr Gastroenterol Rep. 2013 Feb;15(2):308. doi: 10.1007/s11894-012-0308-y.
8
Severe hyponatremia is a better predictor of mortality than MELDNa in patients with cirrhosis and refractory ascites.严重低钠血症是肝硬化伴难治性腹水患者死亡率的更好预测指标,优于 MELDNa。
J Hepatol. 2012 Aug;57(2):274-80. doi: 10.1016/j.jhep.2012.03.018. Epub 2012 Apr 17.
9
Management of hepatorenal syndrome in patients with cirrhosis.肝硬化患者肝肾综合征的管理。
Nat Rev Nephrol. 2011 Aug 9;7(9):517-26. doi: 10.1038/nrneph.2011.96.
10
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.中等量腹水可识别出等待肝移植的低终末期肝病模型评分患者,此类患者具有较高的死亡风险。
Liver Transpl. 2011 Feb;17(2):129-36. doi: 10.1002/lt.22218.